Lonjakan kasus campak di AS memicu upaya pengembangan obat

Amerika Serikat sedang mengalami jumlah kasus campak tertinggi dalam beberapa dekade di tengah penurunan tingkat vaksinasi. Para peneliti mulai mengembangkan pengobatan untuk virus tersebut serta bagi individu yang rentan.

Hingga saat ini, efektivitas vaksinasi campak berarti hanya terdapat sedikit insentif medis atau finansial untuk menciptakan pengobatan bagi penyakit tersebut.

Seiring meningkatnya jumlah kasus, para ilmuwan kini sedang mengerjakan obat-obatan untuk membantu mereka yang terinfeksi atau menghadapi risiko lebih tinggi dari virus ini.

Pergeseran ini mencerminkan perubahan kondisi kesehatan masyarakat di negara tersebut.

Artikel Terkait

A volunteer receiving a needle-free vaccine in a lab with AI-designed virus models in the background.
Gambar dihasilkan oleh AI

AI-designed “pan-sarbecovirus” vaccine candidate reports early safety and immune-response signals in first human trial

Dilaporkan oleh AI Gambar dihasilkan oleh AI Fakta terverifikasi

A needle-free, DNA-based vaccine candidate designed using machine-learning methods has completed a first-in-human Phase 1 study in the UK, with researchers reporting it was well tolerated and induced immune responses against multiple viruses in the sarbecovirus group, which includes SARS-CoV, SARS-CoV-2 and related bat coronaviruses.

Researchers at Georgia State University have developed an oral drug that stopped a measles-like virus from transmitting between ferrets via air or contact. The treatment worked when given before or after exposure and shortened illness duration.

Dilaporkan oleh AI

The São Paulo State Health Department confirmed two new measles cases in the state capital on Tuesday (30), bringing the total infections recorded in the state in 2026 to seven.

An experimental mRNA vaccine has demonstrated effectiveness against three strains of Ebola virus in rodent tests. The vaccine targets Zaire, Sudan and Bundibugyo viruses. Researchers developed it amid an ongoing outbreak of Bundibugyo virus in Africa.

Dilaporkan oleh AI

Researchers have used genetically modified phages to harness pre-existing vaccine immunity and destroy cancer cells in mice. The approach eradicated tumors in 44 percent of treated animals with no recurrence after a year.

Situs web ini menggunakan cookie

Kami menggunakan cookie untuk analisis guna meningkatkan situs kami. Baca kebijakan privasi kami untuk informasi lebih lanjut.
Tolak